Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1 3Phase 2 1Phase 1/2 1

Status

Completed 5Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 1911Neoplasms 1531Prostatic Neoplasms 753Colorectal Neoplasms 715Lung Neoplasms 583Motor Activity 393Head and Neck Neoplasms 328Colonic Neoplasms 312Uterine Cervical Neoplasms 300Pain 248Pancreatic Neoplasms 246Anxiety Disorders 221Rectal Neoplasms 214Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 194Stomach Neoplasms 192Polycystic Ovary Syndrome 188Ovarian Neoplasms 186Precursor Cell Lymphoblastic Leukemia-Lymphoma 178Brain Neoplasms 169Depression 166Urinary Bladder Neoplasms 165Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 138Lymphoma 136Lymphoma, Follicular 128Obesity 127

Interventions

Water 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Completed × Urinary Bladder Diseases × Clear all
NCT05643963 2025-12-11

The COOKER-BLADDER Trial

Hospital Centre Biel/Bienne

Phase NA Completed
13 enrolled
Genitourinary

Urinary Bladder Diseases, Carcinogenesis

NCT03257293 2021-04-27

A Trial of a Modified Cystoscopy Method to Reduce Pain Perception

Western University, Canada

Phase NA Completed
93 enrolled
Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Hematuria

NCT03591367 2019-11-04

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

Mansoura University

Phase NA Completed
115 enrolled
Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms

NCT01803295 2017-06-16

OPTIMA

UroGen Pharma Ltd.

Phase NA Completed
80 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT02891460 2016-09-08

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

UroGen Pharma Ltd.

Phase NA Completed
18 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡